These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 8918407)

  • 1. Circulating antibodies against p53 protein in patients with ovarian carcinoma. Correlation with clinicopathologic features and survival.
    Angelopoulou K; Rosen B; Stratis M; Yu H; Solomou M; Diamandis EP
    Cancer; 1996 Nov; 78(10):2146-52. PubMed ID: 8918407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum anti-p53 autoantibodies in primary resected non-small-cell lung carcinoma.
    Iizasa T; Fujisawa T; Saitoh Y; Hiroshima K; Ohwada H
    Cancer Immunol Immunother; 1998 Aug; 46(6):345-9. PubMed ID: 9756419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic mapping of p53 immunogenicity in pancreatic, ovarian, and breast cancers.
    Katchman BA; Barderas R; Alam R; Chowell D; Field MS; Esserman LJ; Wallstrom G; LaBaer J; Cramer DW; Hollingsworth MA; Anderson KS
    Proteomics Clin Appl; 2016 Jul; 10(7):720-31. PubMed ID: 27121307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The presence of anti-p53 antibodies in sera prior to thoracic surgery in non small cell lung cancer patients: its implications on tumor volume, nodal involvement, and survival.
    Bergqvist M; Brattström D; Lamberg K; Hesselius P; Wernlund J; Larsson A; Wagenius G
    Neoplasia; 2003; 5(4):283-7. PubMed ID: 14511399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen-Mimic Nanoparticles in Ultrasensitive on-Chip Integrated Anti-p53 Antibody Quantification.
    Kang S; Yuan D; Barber R; Davis JJ
    ACS Sens; 2024 Mar; 9(3):1475-1481. PubMed ID: 38441485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The presence of autoantibodies is associated with improved overall survival in lung cancer patients.
    Jing K; Zhao H; Cai J; Chen L; Zheng P; Ouyang L; Li G; Wang R
    Front Oncol; 2023; 13():1234847. PubMed ID: 37799460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-diagnostic circulating p53 autoantibodies and subsequent lung cancer risk in low-income African and European Americans.
    Yoon HS; Zheng W; Cai H; Wu J; Shidal C; Wang J; Shu XO; Waterboer T; Blot WJ; Cai Q
    Cancer Epidemiol; 2022 Dec; 81():102288. PubMed ID: 36332502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutated p53 in HGSC-From a Common Mutation to a Target for Therapy.
    Saleh A; Perets R
    Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential diagnostic value of serum p53 antibody for detecting colorectal cancer: A meta-analysis.
    Meng R; Wang Y; He L; He Y; Du Z
    Oncol Lett; 2018 Apr; 15(4):5489-5496. PubMed ID: 29556296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevation of TP53 Autoantibody Before CA125 in Preclinical Invasive Epithelial Ovarian Cancer.
    Yang WL; Gentry-Maharaj A; Simmons A; Ryan A; Fourkala EO; Lu Z; Baggerly KA; Zhao Y; Lu KH; Bowtell D; Jacobs I; Skates SJ; He WW; Menon U; Bast RC;
    Clin Cancer Res; 2017 Oct; 23(19):5912-5922. PubMed ID: 28637689
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognostic Role of Serum Antibody Immunity to p53 Oncogenic Protein in Ovarian Cancer: A Systematic Review and a Meta-Analysis.
    Garziera M; Montico M; Bidoli E; Scalone S; Sorio R; Giorda G; Lucia E; Toffoli G
    PLoS One; 2015; 10(10):e0140351. PubMed ID: 26451959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P53, bcl-2, ki-67 li (labeling index) status in benign, proliferative, and malignant ovarian surface epithelial neoplasms.
    Gursan N; Sipal S; Calik M; Gundogdu C
    Eurasian J Med; 2009 Apr; 41(1):10-4. PubMed ID: 25610057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of serum p53 antibody measurement in colorectal cancer: an examination of 1384 primary colorectal cancer patients.
    Yamaguchi T; Takii Y; Maruyama S
    Surg Today; 2014 Aug; 44(8):1529-35. PubMed ID: 23975589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential diagnostic value of serum p53 antibody for detecting esophageal cancer: a meta-analysis.
    Zhang J; Xv Z; Wu X; Li K
    PLoS One; 2012; 7(12):e52896. PubMed ID: 23285221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usage of cancer associated autoantibodies in the detection of disease.
    Dudas SP; Chatterjee M; Tainsky MA
    Cancer Biomark; 2010; 6(5-6):257-70. PubMed ID: 20938086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 autoantibodies as potential detection and prognostic biomarkers in serous ovarian cancer.
    Anderson KS; Wong J; Vitonis A; Crum CP; Sluss PM; Labaer J; Cramer D
    Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):859-68. PubMed ID: 20200435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies to tumor-associated antigens in epithelial ovarian carcinoma.
    Piura B; Piura E
    J Oncol; 2009; 2009():581939. PubMed ID: 20145720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond CA125: the coming of age of ovarian cancer biomarkers. Are we there yet?
    Sasaroli D; Coukos G; Scholler N
    Biomark Med; 2009 Jun; 3(3):275-288. PubMed ID: 19684876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 autoantibodies, cytokine levels and ovarian carcinogenesis.
    Tsai-Turton M; Santillan A; Lu D; Bristow RE; Chan KC; Shih IeM; Roden RB
    Gynecol Oncol; 2009 Jul; 114(1):12-7. PubMed ID: 19398128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen-specific immunotherapy of cervical and ovarian cancer.
    Hung CF; Wu TC; Monie A; Roden R
    Immunol Rev; 2008 Apr; 222():43-69. PubMed ID: 18363994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.